Kellogg Eye Center, University of Michigan

Ann Arbor, Michigan 48105

0 studies enrolling now · 10 studies all time

What they study most

Diabetic Macular Edema, Diabetic Retinopathy, Eye Diseases, Eye Diseases Hereditary, Macular Edema, Macular Telangiectasia Type 2, Proliferative Diabetic Retinopathy, Retinal Degeneration, Retinal Disease, Retinal Dystrophies, Retinitis Pigmentosa, Retinitis Pigmentosa 11

Studies at this site

• Rate of Progression in EYS Related Retinal Degeneration — Completed
• Rate of Progression in USH2A-related Retinal Degeneration — Running, not enrolling
• A Repeat-Dose, Open-Label, Two Arm Safety and Efficacy Study of Two Doses of VP-001 Administered Intravitreally in Participants With Confirmed PRPF31 Mutation-Associated Retinal Dystrophy, Including Participants Previously Treated With VP001 — Running, not enrolling
• Serine and Fenofibrate Study in Patients With MacTel Type 2 — Running, not enrolling
• Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy Trial — Completed
• Anti-VEGF vs. Prompt Vitrectomy for VH From PDR — Completed
• PROMINENT-Eye Ancillary Study (Protocol AD) — Stopped early
• Treatment for CI-DME in Eyes With Very Good VA Study — Completed
• PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial — Completed
• Multicenter Uveitis Steroid Treatment (MUST) Trial — Completed